Back to search
FDAFDA · Food and drugs·Recall number Z-1261-2022

AXIUM DETACHABLE COIL SYSTEM REF QC-4-12-HELIX; Axium Detachable Coil System REF QC-10-30-3D;

Published June 22, 2022 · Recall initiated: April 27, 2022

Summary

FDA records medical device Class II recall Z-1261-2022, published June 22, 2022 and initiated April 27, 2022. Recalling firm: Micro Therapeutics, Inc.; Status: Ongoing; Reported quantity: 96 systems; Lot: Product Number: QC-4-12-HELIX UDI-DI (GTIN) Code: 00847536029590 Lot Number: B240079 Product Number: QC-10-30-3D UDI-DI (GTIN) Code: 00847536030138 Lot Number: B240084. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to incorrect size and configuration labeling of the detachable coil system.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Micro Therapeutics, Inc.
Distributor
International distribution in the countries of China and Republic of Korea.
Lot
Product Number: QC-4-12-HELIX UDI-DI (GTIN) Code: 00847536029590 Lot Number: B240079 Product Number: QC-10-30-3D UDI-DI (GTIN) Code: 00847536030138 Lot Number: B240084
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was AXIUM DETACHABLE COIL SYSTEM REF QC-4-12-HELIX; Axium Detachable Coil System REF QC-10-30-3D; recalled?

Yes. FDA published recall Z-1261-2022 on June 22, 2022. Reported hazard: Due to incorrect size and configuration labeling of the detachable coil system.

What should I do if I have this product?

Voluntary: Firm initiated · Letter